GSK news

Latest 10 stories · newest Nov 6, 2026

GSK

'US Measles Cases Top 5,000 for the First Time Since the 1990s' - Bloomberg

News Nov 6, 2026 sentiment +0.10 Source: benzinga.com ↗

GSK

Novavax's Second-Largest Shareholder Sells $32.6 Million in Stock, Ends Activist Push

News Oct 19, 2026 sentiment -0.30 Source: benzinga.com ↗

GSK

AnaptysBio Announces Q2 FY2026 Results and Jemperli Updates

Jemperli global net sales rose 34% year-over-year to $644 million. The company reported positive interim results for the AZUR-1 pivotal trial and anticipates a 2027 FDA decision on expansion to rectal cancer.

Earnings Sep 21, 2026 sentiment +0.80 SEC filing ↗

GSK

8 Health Care Stocks Whale Activity In Today’s Session

Options Sep 7, 2026 sentiment 0.00 Source: benzinga.com ↗

GSK

Sensodyne Maker Haleon Leverages Eye-Level Shelf Placement To Outpace Rivals-Report

News Sep 4, 2026 sentiment 0.00 Source: benzinga.com ↗

GSK

Measles Kills 2 in Pennsylvania: What Do Prediction Markets Say About the Disease?

Markets Aug 25, 2026 sentiment 0.00 Source: benzinga.com ↗

GSK

Dr. Oz Says The MMR Vaccine Is Not 'Lethal' as Trump Administration Faces Questions Over Vaccine Policy

News Aug 24, 2026 sentiment 0.00 Source: benzinga.com ↗

GSK

'Trump Trump Administration Is Working On An Executive Order That Would Split Childhood MMR Vaccine Into Three Shots And Delivering Vaccines At Separate Medical Visits' - Axios

News Aug 10, 2026 sentiment 0.00 Source: benzinga.com ↗

GSK

U.S. CDC Says As Of August 6, 2,465 Confirmed Measles Cases Were Reported In U.S. In 2026; There Have Been 38 New Measles Outbreaks Reported In 2026, And 94% Of Confirmed Cases Are Outbreak-Associated

Biotech Aug 7, 2026 sentiment 0.00 Source: benzinga.com ↗

GSK

GSK to acquire Nuvalent in merger agreement dated June 9, 2026

GlaxoSmithKline LLC agreed to acquire Nuvalent, Inc. through a merger with subsidiary Harmony Row Acquisition Co., with terms outlined in an executed agreement and plan of merger. The transaction represents a significant consolidation in the pharmaceutical sector, combining GSK's established operati…

M&A Jun 9, 2026 sentiment +0.70 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same GSK feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/GSK/newsSTART FREE